Sky Century Investment (SKYI) Net Equity Issued and Repurchased (2013 - 2026)
Sky Century Investment's (SKYI) quarterly Net Equity Issued and Repurchased came in at $85000.0 in Q2 2026, up 1488.79% on a QoQ basis from $5350.0 in Q4 2013.
Sky Century Investment (SKYI) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $85000.0 in Q2 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $85000.0 in Q2 2026; TTM through May 2026 was $85000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $29094.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q2 2026 stood at $85000.0, up from $5350.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for SKYI reached as high as $85000.0 in Q2 2026 and fell as low as $85000.0 in Q2 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | 85,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 85,000.00 |
| May 31, 2026 | 85,000.00 |
| Nov 30, 2013 | 5,350.00 |
| Nov 30, 2013 | 5,350.00 |